object
nasopharyng
swab
asthmat
children
symptomfre
period
examin
presenc
adenovirus
rhinovirus
coronavirus
control
group
healthi
individu
includ
studi
polymeras
chain
reaction
use
detect
adenoviru
dna
rhinoviru
coronaviru
complementari
dna
fragment
amplifi
genet
materi
visual
use
agaros
gel
electrophoresi
result
adenoviru
dna
found
asthmat
children
rhinoviru
rna
coronaviru
rna
adenoviru
dna
detect
one
nasopharyng
swab
healthi
control
rest
control
sampl
neg
conclus
persist
presenc
virus
upper
respiratori
tract
asthmat
children
show
possibl
connect
viral
infect
asthma
asthma
frequent
chronic
respiratori
diseas
affect
children
asthma
induc
allergen
studi
intens
pathogenesi
well
defin
addit
allergen
respiratori
virus
proven
import
factor
provok
asthmat
attack
virusinduc
damag
respiratori
epithelium
result
local
intensifi
activ
variou
cell
involv
immun
respons
presenc
virus
respiratori
tract
form
perman
sourc
foreign
protein
might
caus
subsequ
patholog
chang
rhinovirus
coronavirus
adenovirus
respiratori
syncyti
viru
paramixovirus
frequent
presum
potenti
caus
virusinduc
asthma
exacerb
vast
number
viru
host
characterist
dictat
type
infect
either
persist
latent
determin
host
respons
result
develop
diseas
destruct
infect
cell
reorgan
viral
antigen
within
cell
cell
membran
commonli
consid
consequ
viru
infect
host
immun
system
final
destruct
virus
studi
nasopharyng
swab
taken
asthmat
children
whose
asthma
well
control
least
week
free
respiratori
infect
sampl
examin
presenc
adenoviru
dna
rhinoviru
coronaviru
rna
fifti
children
age
year
moder
asthma
includ
studi
five
subsequ
nasopharyng
swab
taken
child
symptomfre
period
least
week
display
symptom
upper
airway
infect
peak
expiratori
flow
rate
pefr
best
pefr
sampl
taken
receiv
inhal
glucocorticoid
fluticason
g
daili
least
month
total
sampl
asthmat
children
sampl
control
group
age
year
examin
presenc
previous
mention
virus
ensur
posit
control
follow
virus
includ
diagnost
procedur
adenoviru
type
type
institut
microbiolog
immunolog
medic
faculti
ljubljana
slovenia
rhinoviru
atcc
usa
human
coronaviru
strain
lot
atcc
usa
sampl
transport
medium
vigor
vortex
subsequ
centrifug
rpm
min
pellet
resuspend
l
pb
kept
l
aliquot
use
isol
dna
two
hundr
microlitr
cell
suspens
use
isol
dna
use
qiaamp
blood
kit
qiagen
gm
bh
germani
one
hundr
microlitr
isol
dna
kept
elut
buffer
unless
immediatli
use
pcr
pcr
reaction
outer
primer
follow
nest
pcr
npcr
inner
primer
two
control
adenoviru
type
includ
pcr
reaction
pcr
carri
volum
l
pcr
mixtur
contain
l
dna
prepar
reaction
buffer
mm
mgcl
mm
dntp
primer
tib
molbiol
berlin
germani
tabl
ul
dna
taq
polymeras
depc
water
reagent
provid
perkin
elmer
new
jersey
usa
reaction
mixtur
place
thermal
cycler
eppendorf
gradient
heat
min
sampl
subject
cycl
denatur
anneal
elong
subsequ
npcr
pair
inner
primer
use
tabl
origin
dna
sampl
replac
amplicon
first
pcr
isol
rna
one
hundr
forti
microlitr
frozen
clinic
materi
use
isol
rna
follow
rneasi
total
rna
purif
protocol
qiagen
gmbh
germani
fifti
microlitr
rna
elut
depc
water
kept
test
pcr
detect
rhinoviru
coronaviru
rna
rna
sampl
revers
transcrib
complementari
dna
copi
cdna
h
reaction
mixtur
contain
reaction
buffer
mm
mgcl
mm
dntp
ul
rnase
inhibitor
ul
amv
revers
transcriptas
random
primer
depc
water
reagent
provid
perkin
elmer
new
jersey
usa
five
microlitr
cdna
product
subsequ
amplifi
pcr
reaction
mixtur
consist
reaction
buffer
mm
mgcl
mm
dntp
ul
dna
taq
polymeras
reagent
provid
perkin
elmer
new
jersey
usa
specif
primer
rhinovirus
coronavirus
tib
molbiol
berlin
germani
tabl
heat
sampl
min
cycl
carri
detect
coronaviru
rna
npcr
perform
use
inner
pair
primer
tabl
accord
protocol
use
adenoviru
npcr
pcr
run
cdna
control
virus
rna
includ
detect
amplifi
product
amplifi
product
visual
gel
incorpor
ethidium
bromid
electrophoresi
amplifi
fragment
expect
length
tabl
pcr
use
outer
pair
primer
yield
neg
result
sampl
except
posit
control
howev
npcr
bp
fragment
observ
sampl
asthmat
children
bp
fragment
signifi
amplif
rhinoviru
rna
sampl
examin
posit
bp
fragment
observ
npcr
indic
amplifi
coronaviru
rna
posit
result
obtain
two
examin
sampl
borderlin
pcr
result
document
three
virus
search
tabl
ii
coexist
nucleic
acid
na
two
three
virus
search
occasion
notic
followup
particular
sampl
show
half
harbour
two
three
differ
viru
na
persist
half
coexist
two
three
differ
na
chang
occasion
four
sampl
examin
truli
neg
test
virus
adenoviru
dna
detect
one
sampl
healthi
individu
rest
neg
search
presenc
adenoviru
rhinoviru
coronaviru
na
upper
respiratori
tract
asthmat
children
symptomfre
period
result
high
number
posit
result
case
posit
adenoviru
dna
rhinoviru
rna
coronaviru
rna
johnston
et
al
found
upper
respiratori
tract
virus
associ
asthma
exacerb
children
howev
result
relat
asymptomat
children
least
week
without
sign
respiratori
infect
nicholson
beasley
want
defin
rate
viru
particip
asthma
exacerb
adult
use
cell
cultur
serolog
surprisingli
low
result
obtain
reason
seem
activ
infect
demonstr
compar
viru
identif
rate
children
adult
subject
demonstr
fall
isol
rate
adult
johnston
maintain
connect
upper
respiratori
infect
asthma
exacerb
long
recogn
import
underestim
previou
studi
defici
virusdetect
method
use
view
possibl
presenc
either
activ
latent
infect
think
well
advis
use
pcr
studi
anoth
reason
use
method
coronavirus
rhinovirus
rather
difficult
grow
cultur
cell
demonstr
viral
dna
rna
persist
present
asthmat
children
even
symptomfre
period
respiratori
virus
infect
upper
respiratori
tract
affect
lower
airway
indirectli
gern
fraenkel
howev
confirm
respiratori
virus
except
coronavirus
data
exist
abl
infect
lower
respiratori
tract
rais
question
effect
relev
asthma
exhibit
get
due
high
viral
na
detect
rate
asthmat
children
compar
lower
detect
rate
control
group
specul
result
could
relat
diseas
glucocorticoid
treatment
sinc
data
suggest
glucocorticoid
therapi
increas
titr
respiratori
virus
prolong
viral
shed
